Position in ZTS
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$70,926
-$4,566 QoQ
Shares Held
600
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Trifecta Capital Advisors, LLC holds $2,103 across 3 Drug Manufacturers - Specialty & Generic names.
All Filings in ZTS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $70,926 | 600 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $75,492 | 600 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $89,840 | 614 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $142,538 | 914 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $150,490 | 914 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $148,918 | 914 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $178,577 | 914 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $158,451 | 914 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $154,657 | 914 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $180,396 | 914 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $159,017 | 914 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $140,178 | 814 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $135,482 | 814 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $2,051 | 14 | Shares | Sole | 2023-01-18 | |
| No filing history on record for this holder in this stock. | ||||||